GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (OISE:ALVO) » Definitions » Other Gross PPE

Alvotech (OISE:ALVO) Other Gross PPE : kr50,510 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Alvotech Other Gross PPE?

Alvotech's Other Gross PPE for the quarter that ended in Mar. 2024 was kr50,510 Mil.

Alvotech's quarterly Other Gross PPE declined from Sep. 2023 (kr47,813 Mil) to Dec. 2023 (kr16,623 Mil) but then increased from Dec. 2023 (kr16,623 Mil) to Mar. 2024 (kr50,510 Mil).

Alvotech's annual Other Gross PPE declined from Dec. 2021 (kr17,630 Mil) to Dec. 2022 (kr6,565 Mil) but then increased from Dec. 2022 (kr6,565 Mil) to Dec. 2023 (kr16,623 Mil).


Alvotech Other Gross PPE Historical Data

The historical data trend for Alvotech's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech Other Gross PPE Chart

Alvotech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
- 15,520.80 17,629.83 6,565.42 16,623.48

Alvotech Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37,909.80 46,411.35 47,813.34 16,623.48 50,510.11

Alvotech Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Alvotech (OISE:ALVO) Business Description

Traded in Other Exchanges
Address
9, rue de Bitbourg, Luxembourg, LUX, L-1273
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.